Ronald Kirk Huntsman - 31 Dec 2021 Form 5 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chief Executive Officer, Director
Signature
/s/ Brad Amman as attorney-in-fact for R. Kirk Huntsman
Issuer symbol
VVOS
Transactions as of
31 Dec 2021
Net transactions value
+$705,000
Form type
5
Filing time
14 Feb 2022, 20:21:10 UTC
Previous filing
22 Sep 2021
Next filing
28 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VVOS Stock Option (Right to Buy) Award $705,000 +125,000 $5.64* 125,000 16 Jun 2021 Common Stock 125,000 $5.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 An option for the purchase of 125,000 shares was granted on June 16, 2021. The option vests one fifth immediately and one-fifth annually on each anniversary date through June 16, 2025.